SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (548)1/31/2004 3:38:52 AM
From: mopgcw  Respond to of 598
 
The only thing I can think of is disappointment over no partner announcement on 131. I think that is next out of the oven.



To: tuck who wrote (548)2/2/2004 7:37:03 PM
From: mopgcw  Read Replies (1) | Respond to of 598
 
I listened to the cc replay and nothing dramatic there.

they did not discuss the halting of the ovarian track for 607 at all. they have $200mm in cash and expect the burn to be $100mm for '04 without benefit of partnering 131.

they have a lot of irons in the fire, so perhaps the expectation that the 750 person trial of T67 will burn cash and prove worthless?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News